Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    KemPharm Inc.

    NASDAQ: KMPH · Real-Time Price · USD
    5.81
    -0.02 (-0.34%)
    At close: Feb 28, 2023, 10:00 PM

    KemPharm Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 23.61M 10.46M 28.65M
    Cost of Revenue
    		 7.42M 343K 2.06M
    Gross Profit
    		 16.2M 10.12M 26.59M
    Operating Income
    		 -87M -24.84M 7.73M
    Interest Income
    		 n/a 760K 248K
    Pretax Income
    		 -90.14M -42.33M -8.52M
    Net Income
    		 -105.51M -41.54M -8.55M
    Selling & General & Admin
    		 54.87M 15.34M 8.7M
    Research & Development
    		 42.09M 19.61M 10.16M
    Other Expenses
    		 n/a n/a n/a
    Operating Expenses
    		 96.96M 34.96M 18.86M
    Interest Expense
    		 -7.35M 335K 376K
    Selling & Marketing Expenses
    		 n/a n/a n/a
    Cost & Expenses
    		 104.38M 35.3M 20.92M
    Income Tax Expense
    		 -15.37M -786K 34K
    Shares Outstanding (Basic)
    		 46.25M 34.49M 29.77M
    Shares Outstanding (Diluted)
    		 46.25M 34.49M 29.77M
    EPS (Basic)
    		 -2.28 -1.2 -0.29
    EPS (Diluted)
    		 -2.28 -1.2 -0.29
    EBITDA
    		 -87M -24.08M 7.98M
    EBIT
    		 n/a -24.33M -8.14M
    Depreciation & Amortization
    		 n/a 760K 248K

    Add to Watchlist